Leadership Overview
Pigeon has 4 executives leading key functions including strategy, operations, and product development.
Driven by a commitment to quality, Pigeon focuses on enhancing the lives of parents and children through innovative product solutions and a dedication to safety and comfort.
Driven by a commitment to quality, Pigeon focuses on enhancing the lives of parents and children through innovative product solutions and a dedication to safety and comfort.
Leadership Roles at Pigeon
Yoichi Nakata - Chairman & Chief Executive Officer
Yoichi Nakata, the Chairman & Chief Executive Officer at Pigeon, directs the overarching corporate strategy and long-term vision for the company. This leadership role involves guiding global market expansion and ensuring sustained financial performance across all business segments. Overseeing the executive team, Chairman & Chief Executive Officer Nakata drives innovation in product development, aligning with Pigeon's mission to support families worldwide. The Chairman & Chief Executive Officer ensures robust governance structures are in place, fostering a culture of accountability and ethical business practices. Yoichi Nakata's strategic direction is critical for navigating complex international markets and maintaining Pigeon's competitive edge in the baby and child care industry. This executive's focus extends to identifying new growth opportunities and optimizing resource allocation to maximize shareholder value and operational efficiency.
Norimasa Kitazawa - President & Chief Executive Officer
Norimasa Kitazawa, the President & Chief Executive Officer at Pigeon, executes the strategic initiatives set forth by the board and Chairman. This role involves direct oversight of daily operations and ensuring seamless integration of product manufacturing and distribution channels. President & Chief Executive Officer Kitazawa champions operational excellence, driving efficiency improvements across the global supply chain and manufacturing facilities. The President & Chief Executive Officer fosters cross-functional collaboration, ensuring product innovation translates effectively into market-ready solutions. Norimasa Kitazawa's leadership is pivotal in maintaining the high standards of quality and safety that define Pigeon's extensive product lines, from baby care essentials to nursing products. This executive's responsibilities include managing key stakeholder relationships and steering the company towards its growth objectives in diverse international territories.
Shigeru Yamashita - President & Chief Operating Officer
Shigeru Yamashita, the President & Chief Operating Officer at Pigeon, manages the intricate operational framework that supports Pigeon's diverse product portfolio. This executive oversees manufacturing, logistics, and quality assurance, ensuring that all products meet stringent safety and performance standards. President & Chief Operating Officer Yamashita drives operational efficiency, implementing advanced manufacturing techniques and optimizing supply chain networks to enhance product availability and reduce costs. The President & Chief Operating Officer collaborates closely with product development teams to ensure seamless transition from concept to scalable production. Shigeru Yamashita's operational leadership is fundamental to Pigeon's ability to deliver reliable baby and child care products, maternity items, and nursing care solutions to families across the globe. This role involves meticulous planning and execution to maintain consistent product quality and meet market demand effectively.
Hiroyuki Masunari - Managing Officer
Hiroyuki Masunari, the Managing Officer at Pigeon, directs critical functions that underpin the company's market presence and product lifecycle management. This executive's purview includes overseeing specific business units and driving strategic projects that enhance Pigeon's product offerings and market penetration. Managing Officer Masunari focuses on the development and implementation of innovative strategies for product categories such as strollers and nursing care products. The Managing Officer ensures alignment between research and development efforts and market needs, fostering continuous improvement across all product lines. Hiroyuki Masunari's leadership contributes significantly to Pigeon's reputation for quality and innovation in the competitive baby and child care sector. This role involves close coordination with sales and marketing teams to ensure effective product launches and sustained market engagement.
Explore Leadership Teams in Manufacturing
Bausch & Lomb is a global eye health company that develops, manufactures and markets healthcare products. The company's products include over-the-counter products, dietary supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. They are based in Vaughan, Ontario, Canada.
Company Leadership

YH
Founded in 1989 and headquartered in Princeton, New Jersey, Integra LifeSciences is a medical technology company that develops and manufactures surgical instruments, neurosurgical devices, and advanced wound care and tissue repair products. Through its Codman Specialty Surgical and Tissue Technologies segments, the company serves neurosurgeons, neurocritical care teams, ENT specialists, plastic and reconstructive surgeons, and general surgeons. Its portfolio includes neurosurgical tools and systems such as dural repair products, cerebrospinal fluid management devices, intracranial monitoring equipment, and cranial stabilization devices, as well as surgical headlamps and general surgical instruments. Integra also provides specialized solutions for acute and chronic wound management, including burns and diabetic foot ulcers, and offers products for soft tissue, bone, nerve, and tendon repair. In ear, nose, and throat care, the company supplies instrumentation, balloon technologies for sinus and eustachian tube dilation, and surgical navigation systems. Sold through direct sales teams and distribution partners to hospitals, surgery centers, and healthcare providers worldwide, Integra LifeSciences positions itself as a comprehensive partner for complex surgical and reconstructive care.
Company Leadership SE

CV
Patterson Companies, Inc. distributes and sells dental and animal health products in the United States, the United Kingdom, and Canada. It operates through Dental and Animal Health segments. The companys Dental segment offers consumable products, such as infection control, restorative materials, hand instruments, and sterilization products; basic and advanced technology dental equipment; patient education systems; and office forms and stationery. This segment also develops and sells technology solutions, such as practice management software and e-commerce solutions. In addition, it offers a range of related services, including software and design, maintenance and repair, and equipment financing services. The companys Animal Health segment distributes animal health products, such as pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritionals, consumable supplies, equipment, and software to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. This segment also offers a range of value-added services to animal health customers. Patterson Companies, Inc. serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in St. Paul.
Company Leadership TP
LK
DS

MiMedx Group, Inc., a biopharmaceutical company, develops and markets regenerative biologics utilizing human placental tissue allografts with patent-protected processes for various sectors of healthcare. It processes the human placental tissue utilizing its proprietary PURION Process to produce allografts. The companys proprietary processing methodology employs aseptic processing techniques in addition to terminal sterilization. Its biomaterial platform technologies include AmnioFix and EpiFix that are tissue technologies processed from human amniotic membrane derived from donated placental tissue for homologous applications; OrthoFlo, an amniotic fluid-derived allograft for homologous applications; Physio, a bone grafting material comprising 100% bone tissue with no added carrier; and CollaFix, a technology platform derived from collagen fiber technology designed to mimic the natural composition, structure, and mechanical properties of musculoskeletal tissues to augment their repair. The company also offers EpiCord, an umbilical cord allograft that provides a connective tissue matrix to replace or supplement damaged or inadequate integumental tissue; AmnioCord, an umbilical cord allograft that offers a protective environment for the healing process; and AmnioFill, a cellular tissue matrix allograft that enhances healing. Its products have applications in the areas of wound care, burns, surgery, orthopedics, spine, sports medicine, ophthalmology, and dentistry. The company sells its products through direct sales force, and independent stocking distributors, and third party representatives in the United States, as well as independent distributors internationally. MiMedx Group, Inc. is headquartered in Marietta,...
Company Leadership
DM
WH
DR